Results 131 to 140 of about 5,939 (161)
Some of the next articles are maybe not open access.

Benralizumab for eosinophilic granulomatosis with polyangiitis

Annals of the Rheumatic Diseases, 2023
Benralizumab is effective in the treatment of eosinophilic asthma and is being investigated for the treatment of other eosinophil-associated diseases. Reports on the use of benralizumab for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) are limited to case reports and small case series.We conducted a multicentre, retrospective ...
Cottu, Adrien   +25 more
openaire   +2 more sources

Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis

New England Journal of Medicine, 2017
Eosinophilic granulomatosis with polyangiitis, first described in the early 1950s by Dr. Jacob Churg and Dr. Lotte Strauss (hence the original name, the Churg–Strauss syndrome), is a rare condition that can affect many organ systems, most commonly the lung, with the majority of patients presenting with asthma symptoms, occasionally complicated by the ...
Djukanović, Ratko, O'Byrne, Paul
openaire   +2 more sources

Eosinophilic granulomatosis with polyangiitis

Folia Otorhinolaryngologiae et Pathologiae Respiratoriae
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic disease in the group of ANCA-associated vasculitides, characterized by a combination of severe eosinophilic asthma, chronic rhinosinusitis, hypereosinophilia, and necrotizing vasculitis of small and medium-sized vessels.
Alexandra M. Nanzer   +5 more
  +4 more sources

Eosinophilic Granulomatosis With Polyangiitis

JAMA Dermatology, 2021
Abraham M, Korman, Catherine G, Chung
openaire   +2 more sources

Eosinophilic fasciitis in eosinophilic granulomatosis with polyangiitis

Rheumatology, 2023
Ole Hudowenz   +3 more
openaire   +2 more sources

Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)

Seminars in Respiratory and Critical Care Medicine, 2018
AbstractEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg–Strauss syndrome, is a systemic necrotizing vasculitis of small- and medium-size vessels, characterized by asthma and blood eosinophilia. EGPA typically occurs in patients with preexisting asthma, and involves the skin, lungs, and peripheral nerves.
Yann, Nguyen, Loïc, Guillevin
openaire   +2 more sources

Benralizumab in eosinophilic granulomatosis with polyangiitis

Medicina Clínica, 2022
Daniel, Laorden   +2 more
openaire   +2 more sources

Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies

Current Rheumatology Reports, 2018
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic disseminated vasculitis associated with extravascular granulomas in patients suffering from asthma and tissue eosinophilia. Current therapies to achieve remission and prevent relapse include glucocorticoids and immunosuppressants like cyclophosphamide.With the right treatment, clinical ...
Erika P, Navarro-Mendoza   +1 more
openaire   +2 more sources

Aortitis in Eosinophilic Granulomatosis With Polyangiitis

JCR: Journal of Clinical Rheumatology, 2023
Hirotaka, Yamamamoto   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy